Literature DB >> 10580012

Application of pharmacogenetics to optimization of mercaptopurine dosing.

F M Balis, P C Adamson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580012     DOI: 10.1093/jnci/91.23.1983

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Genetic diversity and new therapeutic concepts.

Authors:  Barkur S Shastry
Journal:  J Hum Genet       Date:  2005-07-23       Impact factor: 3.172

2.  Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.

Authors:  Ahmed F Hawwa; Jeff S Millership; Paul S Collier; Koen Vandenbroeck; Anthony McCarthy; Sid Dempsey; Carole Cairns; John Collins; Colin Rodgers; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

3.  Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.

Authors:  Ahmed F Hawwa; Paul S Collier; Jeff S Millership; Anthony McCarthy; Sid Dempsey; Carole Cairns; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2008-09-23       Impact factor: 4.335

Review 4.  A composite screening tool for medication reviews of outpatients: general issues with specific examples.

Authors:  Peter A G M De Smet; Wilma Denneboom; Cees Kramers; Richard Grol
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

5.  Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan

Authors:  Mervat Alsous; Al-Motassem Yousef; Mariam Abdel Jalil; Mohammed Zawiah; Shorouq Yacoub; Deema Momani; Alia Gharabli; Suha Omar; Rawad Rihani
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.